Article Information
History
- January 15, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- James G. Truslow, PhD1,
- Shinichi Goto, MD, PhD1,2,
- Max Homilius, PhD1,2,
- Christopher Mow, MS3,4,
- John M. Higgins, MD, PhD3,5,6,
- Calum A. MacRae, MD, PhD1,2 and
- Rahul C. Deo, MD, PhD1,2,*
- 1One Brave Idea and Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
- 2Department of Medicine, Harvard Medical School, Boston, MA, USA
- 3Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
- 4Partners Healthcare Enterprise Research Information Systems, Boston, Massachusetts, USA
- 5Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
- 6Department of Systems Biology, Harvard Medical School, Boston, Massachusetts USA
- ↵*To whom correspondence should be addressed:
Rahul C. Deo, MD, PhD, One Brave Idea / Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA, rdeo{at}bwh.harvard.edu
Posted January 15, 2021.
Scalable cardiovascular risk assessment using artificial intelligence-enabled event adjudication and widely available hematologic predictors
